NANG KUANG PHARM CO FDA Approval ANDA 204329

ANDA 204329

NANG KUANG PHARM CO

FDA Drug Application

Application #204329

Application Sponsors

ANDA 204329NANG KUANG PHARM CO

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUSEQ 3MG BASE/3ML0IBANDRONATE SODIUMIBANDRONATE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2021-06-16

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

NANG KUANG PHARM CO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204329
            [companyName] => NANG KUANG PHARM CO
            [docInserts] => ["",""]
            [products] => [{"drugName":"IBANDRONATE SODIUM","activeIngredients":"IBANDRONATE SODIUM","strength":"EQ 3MG BASE\/3ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/16\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-06-16
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.